Project Grant HT9425261E086
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $981K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- The University of Pennsylvania received a $777,537 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. This research award supports an investigation into the associations between blood-based neurodegenerative biomarker trajectories and the risk of epilepsy, post-traumatic epilepsy, and dementia. The project will be conducted at the University of Pennsylvania's...
- Federal Grant Award Summary The University of Pennsylvania received a $581,220 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award supports research titled "Accelerating Post-Traumatic Epilepsy Research Through Data Integration and Verifiable Analysis at Scale," which will be conducted in Philadelphia, Pennsylvania. This modification adds $74,588...
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,159,317 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2029. The award supports the EDISYN-LFS (Early Detection in Syndromic Neoplasms for Patients with Li-Fraumeni Syndrome) research initiative, which focuses on advancing early detection methodologies and biomarker discovery for cancer...
- The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
- Federal Project Grant Award Summary The University of Pennsylvania received a $812,487 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2028. The award supports research titled "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer," to be conducted at the university's Philadelphia campus. Under this three-year...
- The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
- The University of Pennsylvania was awarded a $390,000 Formula Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 15, 2025, will fund research to exploit synthetic essential genetic dependencies to define oncogenic signaling networks and establish novel targets for lung adenocarcinoma therapy. This work aims to transform healthcare for military service members, veterans, and the broader public by developing...
- Federal Grant Award Summary The University of Pennsylvania received a $1,305,270 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to establish the Ovarian Cancer Academy: Advancing Ovarian Cancer Research Through Mentorship, Networking, and Collaborations. The four-year award, which commenced on September 30, 2025 and extends through September 29, 2029, will be performed at the university's Philadelphia campus. This...
- The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....